Our results are consistent with previous studies, where the expression of PD-L1 in GBM is associated with poor prognosis, thus GBM cells can regulate the expression of the PD-L1/PD-1 axis to evade immune surveillance and suppress the antitumor activity of CD8 + T cells [36]. The gene discussed is CD8A; the disease is glioblastoma.